XPD Asp312Asn polymorphism is a risk factor for prostate cancer
Journal of Cancer Research & Clinical Oncology, 06/04/2012
Liao SG et al. – The results of this meta–analysis indicate that the Xeroderma pigmentosum Group D (XPD) Asp312Asn polymorphism is a risk factor for prostate cancer development.



